Skip to main content
Figure 1 | Annals of Clinical Microbiology and Antimicrobials

Figure 1

From: Susceptibility of important Gram-negative pathogens to tigecycline and other antibiotics in Latin America between 2004 and 2010

Figure 1

Percentage of Escherichia coli and Klebsiella pneumoniae isolates identified as ESBL producers in each Latin American countryainvolved in T.E.S.T. (2004–2010). E. coli N values: Argentina, 101/769; Brazil, 43/247; Chile, 94/271; Colombia, 58/519; Guatemala, 81/263; Honduras, 31/77; Mexico, 398/1044; Panama, 16/100; Venezuela, 32/218; Latin America, 870/3581. K. pneumoniae N values: Argentina, 270/694; Brazil, 105/214; Chile, 147/243; Colombia, 81/432; Guatemala, 96/189; Honduras, 55/75; Mexico, 191/754; Panama, 35/89; Venezuela, 36/209; Latin America, 1045/2962. a Data from El Salvador, Jamaica and Nicaragua are not included in the analysis by country because fewer than 50 isolates were collected; however, their data are included in the total for Latin America.

Back to article page